The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer’s Disease

by Jacques Hugon, Claire Paquet
Published 2021-03-01

PKR involvement in Alzheimer’s disease

by Jacques Hugon, François Mouton-Liger, Julien Dumurgier, Claire Paquet
Published 2017-10-01

Blood-Based Kinase Assessments in Alzheimer’s Disease

by Jacques Hugon, Jacques Hugon, François Mouton-Liger, François Mouton-Liger, Emmanuel Cognat, Emmanuel Cognat, Julien Dumurgier, Julien Dumurgier, Claire Paquet, Claire Paquet
Published 2018-11-01

Are ketogenic diets promising for Alzheimer’s disease? A translational review

by Matthieu Lilamand, Baptiste Porte, Emmanuel Cognat, Jacques Hugon, François Mouton-Liger, Claire Paquet
Published 2020-04-01

Cognitive decline and brainstem hypometabolism in long COVID: A case series

by Jacques Hugon, Mathieu Queneau, Marta Sanchez Ortiz, Eva Flore Msika, Karim Farid, Claire Paquet
Published 2022-04-01

Dissociation of Akt/PKB and ribosomal S6 kinase signaling markers in a transgenic mouse model of Alzheimer’s disease

by Milena Damjanac, Agnès Rioux Bilan, Marc Paccalin, Raymond Pontcharraud, Bernard Fauconneau, Jacques Hugon, Guylène Page
Published 2008-02-01

Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease

by Frédéric Moynier, Marie Le Borgne, Esther Lahoud, Brandon Mahan, Francois Mouton‐Liger, Jacques Hugon, Claire Paquet
Published 2020-01-01

Hepatitis C virus reveals a novel early control in acute immune response.

by Noëlla Arnaud, Stéphanie Dabo, Daisuke Akazawa, Masayoshi Fukasawa, Fumiko Shinkai-Ouchi, Jacques Hugon, Takaji Wakita, Eliane F Meurs
Published 2011-10-01

Inverse association between CSF Aβ 42 levels and years of education in mild form of Alzheimer's disease: The cognitive reserve theory

by Julien Dumurgier, Claire Paquet, Sarah Benisty, Claire Kiffel, Claude Lidy, François Mouton-Liger, Hugues Chabriat, Jean-Louis Laplanche, Jacques Hugon
Published 2010-11-01

Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays

by Annika Öhrfelt, Julien Dumurgier, Henrik Zetterberg, Agathe Vrillon, Nicholas J. Ashton, Hlin Kvartsberg, Elodie Bouaziz-Amar, Jacques Hugon, Claire Paquet, Kaj Blennow
Published 2020-12-01

CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease

by François Mouton-Liger, Julien Dumurgier, Emmanuel Cognat, Claire Hourregue, Henrik Zetterberg, Hugo Vanderstichele, Eugeen Vanmechelen, Elodie Bouaziz-Amar, Kaj Blennow, Jacques Hugon, Claire Paquet
Published 2020-07-01

PKR modulates abnormal brain signaling in experimental obesity.

by Mariko Taga, François Mouton-Liger, Malha Sadoune, Sarah Gourmaud, Jenny Norman, Marion Tible, Sylvie Thomasseau, Claire Paquet, James A R Nicoll, Delphine Boche, Jacques Hugon
Published 2018-01-01

Cerebrospinal fluid PKR level predicts cognitive decline in Alzheimer's disease.

by Julien Dumurgier, Francois Mouton-Liger, Pauline Lapalus, Magali Prevot, Jean-Louis Laplanche, Jacques Hugon, Claire Paquet, Groupe d’Investigation du Liquide Cephalorachidien (GIL) Study Network
Published 2013-01-01

Hepatitis C virus controls interferon production through PKR activation.

by Noëlla Arnaud, Stéphanie Dabo, Patrick Maillard, Agata Budkowska, Katerina I Kalliampakou, Penelope Mavromara, Dominique Garcin, Jacques Hugon, Anne Gatignol, Daisuke Akazawa, Takaji Wakita, Eliane F Meurs
Published 2010-05-01

Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease: a discovery cohort study

by Agathe Vrillon, François Mouton-Liger, Matthieu Martinet, Emmanuel Cognat, Claire Hourregue, Julien Dumurgier, Elodie Bouaziz-Amar, Ann Brinkmalm, Kaj Blennow, Henrik Zetterberg, Jacques Hugon, Claire Paquet
Published 2022-05-01

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice

by Matthieu Lilamand, Josué Clery, Agathe Vrillon, François Mouton-Liger, Emmanuel Cognat, Sinead Gaubert, Claire Hourregue, Matthieu Martinet, Julien Dumurgier, Jacques Hugon, Elodie Bouaziz-Amar, Claire Paquet
Published 2022-11-01

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

by Adla Boumenir, Emmanuel Cognat, Severine Sabia, Claire Hourregue, Matthieu Lilamand, Aline Dugravot, Elodie Bouaziz-Amar, Jean-Louis Laplanche, Jacques Hugon, Archana Singh-Manoux, Claire Paquet, Julien Dumurgier
Published 2019-03-01

Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study

by Karl Götze, Agathe Vrillon, Elodie Bouaziz-Amar, François Mouton-Liger, Jacques Hugon, Matthieu Martinet, Julien Dumurgier, Emmanuel Cognat, Henrik Zetterberg, Kaj Blennow, Claire Hourrègue, Claire Paquet, Matthieu Lilamand
Published 2023-01-01

Exacerbated CSF abnormalities in younger patients with Alzheimer's disease

by Julien Dumurgier, Audrey Gabelle, Olivier Vercruysse, Stéphanie Bombois, Jean-Louis Laplanche, Katell Peoc'h, Susanna Schraen, Bernard Sablonnière, Florence Pasquier, Jacques Touchon, Sylvain Lehmann, Jacques Hugon, Claire Paquet
Published 2013-06-01

Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau.

by Aysha S Mohamed Lafirdeen, Emmanuel Cognat, Severine Sabia, Claire Hourregue, Matthieu Lilamand, Aline Dugravot, Elodie Bouaziz-Amar, Jean-Louis Laplanche, Jacques Hugon, Archana Singh-Manoux, Claire Paquet, Julien Dumurgier
Published 2019-01-01